Legend Biotech (LEGN) Current Assets (2019 - 2025)

Legend Biotech has reported Current Assets for 7 years, with the latest figure at $1.2 billion in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 2.87% year-over-year to $1.2 billion; the trailing twelve-month figure through Dec 2025 stood at $1.2 billion (down 2.87% YoY), and the FY2025 full-year result was $1.2 billion, down 2.87% from the prior year.
• Current Assets for Q4 2025 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
• The five-year high for Current Assets was $1.6 billion in Q2 2023, with the low at $475074.0 in Q1 2021.
• Historically, Current Assets has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2025.
• Annual changes were most pronounced in 2022 — Current Assets surged 181849.97% — and 2024, when it slipped 14.28%.
• Legend Biotech's Current Assets stood at $949.8 million in 2021, then grew by 15.72% to $1.1 billion in 2022, then jumped by 36.27% to $1.5 billion in 2023, then slipped by 14.28% to $1.3 billion in 2024, then dropped by 2.87% to $1.2 billion in 2025.
• The last three Current Assets figures came in at $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025), per Business Quant data.